申请人:——
公开号:US20030139394A1
公开(公告)日:2003-07-24
The invention relates to compounds of the formula I
1
and their tautomeric forms, possible enantiomeric and diastereomeric forms and their prodrugs, and to their preparation and use, where A, B, R
1
and X
1
have the meanings given in the description.
本发明涉及公式I1化合物及其互变异构体,可能的对映异构体和二对映异构体以及它们的前药,以及它们的制备和使用,其中A、B、R1和X1的含义如说明书所述。